Posted 5th January 2026
Posted 1 week ago
By NHP Office
NHP Cellular Therapy Operational Group (CTG)
Learn more about the NHP Cellular Therapy Operational Group (CTG)
The haemoglobinopathy community is constantly evolving. Here we share some highlights of the NHP, its network members and its stakeholders regarding advances in their improvement, harmonisation and equity goals and efforts.
Learn more about the NHP Cellular Therapy Operational Group (CTG)
The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.
First iteration of the mortality reporting pathway for haemoglobinopathies.
Learn more about the NHP Cellular Therapy Operational Group (CTG)
The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.
First iteration of the mortality reporting pathway for haemoglobinopathies.
The guidance provides good practice advice for medical examiners on recognising the impact of SCD in various contexts including deaths and coroner referrals.
The NHP activity report for 2023/2024 (published 21 November 2024) gives an overview of its core and partner-related activities.
Following the stepping down of Professor Baba Inusa, Dr Kate Gardner has been appointed the new NHP Chair.